Case Report: Osimertinib-induced acute interstitial lung disease

Osimertinib is a third-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that selectively targets EGFR-TKI-sensitive mutations, thereby inhibiting tumor cell proliferation, migration, and invasion. Herein, we present a case of osimertinib-induced interstit...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Zhiwu Lin, Liang Wu, Yang Yu, Jiudong Jiang, Yanchun Yang, Guibao Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Subjects:
adverse drug reaction
osimertinib
interstitial lung disease
lung cancer
EGFR-TKI
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1608733/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1608733/full

Similar Items